Physician profile
Judith Hernandez
NPI 1124284757
$1,626.85
in general payments reported to CMS, 2019-2025
17 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2021: $93.97 · 2022: $370 · 2023: $170 · 2024: $201 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $330.07 | 2019-2025 | Rayaldee |
| Astrazeneca Pharmaceuticals LP | $237.08 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $215.13 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $172.81 | 2024-2025 | |
| Horizon Therapeutics Plc | $149.41 | 2019-2023 | Krystexxa |
| Akebia Therapeutics INC | $122.92 | 2019-2022 | |
| Glaxosmithkline, LLC. | $92.73 | 2023-2025 | Benlysta, Jesduvroq |
| Fresenius USA Marketing, INC. | $86.59 | 2019-2023 | |
| Amgen INC. | $40.16 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.40 | 2023-2024 | Jardiance, Tradjenta, Synjardy |
| Ge Healthcare | $31.13 | 2025 | |
| Aurinia Pharma U.S., INC. | $28.63 | 2024 | Lupkynis |
| Travere Therapeutics, INC. | $19.44 | 2025 | |
| Vifor Pharma, INC. | $18.20 | 2022 | |
| Ani Pharmaceuticals, INC. | $17.36 | 2025 | Purified Cortrophin Gel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.91 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.